Republicans in Congress are advancing significant federal restrictions on gender-affirming care for transgender minors as the House prepares to vote on two pivotal bills this week. These legislative measures come just before lawmakers break for the holiday season, indicating an urgency among proponents to enact these changes.
The first bill, introduced by Rep. Marjorie Taylor Greene (R-Ga.), seeks to amend existing laws regarding female genital mutilation to classify gender-affirming treatments, including surgeries and hormone therapies, as forms of “genital or bodily mutilation” and “chemical castration.” The second bill, proposed by Rep. Dan Crenshaw (R-Texas), aims to prevent Medicaid from funding such care for minors. This legislative push reflects a broader strategy by the Republican administration to restrict access to gender-affirming care, a move that has drawn significant scrutiny from health policy experts.
According to Lindsey Dawson, director of LGBTQ health policy at KFF, these bills represent a “sweeping ban” that would significantly limit healthcare options for young people. This development not only highlights the contentious nature of healthcare policy in the U.S. but also raises critical questions about the implications for healthcare providers and the regulatory landscape surrounding gender-affirming treatments.
Use the database as your supply chain compass →
